esc 2022: the momentum 3 study: 5-year results from heartmate 3 lvad therapy | dr mandeep mehra
Published 2 years ago • 477 plays • Length 7:26Download video MP4
Download video MP3
Similar videos
-
10:23
mandeep mehra, esc 2022: heartmate 3™ lvad for heart failure, 2- and 5-year results of momentum 3
-
34:44
setting the standard in lvad therapy with momentum 3 long-term clinical evidence
-
8:27
acc 2018: mandeep mehra - momentum 3
-
1:53
evaluation of 3d left ventricular volumes at transthoracic echocardiography (tte)
-
1:54
dr. kurlansky explains significance of final momentum 3 results (heartmate iii lvad)
-
40:29
7. minimally invasive mitral valve repair cases - drs. meineri, davierwala, neethling
-
1:24:30
45th course , 20220508 , evaluation of mitral stenosis & tricuspid stenosis
-
20:09
8 - dr. wendy tsang - 3d tee acquisition: tricuspid valve
-
4:21
esc tv at acc.18 - momentum 3 - long term outcomes
-
2:12
how to assess the right ventricle in covid 19 with echocardiography
-
33:46
how to map and ablate lv summit ventricular arrhythmias dr ghalia al mohani
-
1:20:10
[tctap 2023] live case & lecture #17: tricuspid
-
4:18
heartmate 3 pump study 'changing practice right now' - medpage today
-
4:52
esc 2022: covid-pact: antithrombotic therapy in critically ill covid-19 pts | dr david d berg
-
2:30
esc 2022: the all-heart trial: allopurionol in the treatment of ischaemic heart disease
-
25:22
cvi2018 session: what are the clinical endpoints for tr? - rebecca hahn, md
-
1:06:00
m3 final 2
-
5:02
esc 2022: emperor-preserved & deliver meta-analysis: sglt2is in heart failure | dr vaduganathan
-
5:00
esc 22: panther: p2y12i vs aspirin monotherapy in pts with cad with prof valgimigli
-
4:45
esc 2022: the emperor-pooled trial: clinical benefits of sglt2i in heart failure | dr faiez zannad
-
1:58
participating in clinical trial of heartmate iii left ventricular assist device (lvad)